Sandra Do Lago Moraes

Sandra Do Lago Moraes

Auto-generated profile, based on publicly available information

Sandra Do Lago Moraes

Division of Clinical Immunology and Allergy, Department of Medicine, School of Medicine

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2008 in Genome Biology
Verified
Journal Article
Open access
PDF file
DNDaniel E Neafsey
Daniel E Neafsey
SSStephen F Schaffner
Stephen F Schaffner
SVSarah K Volkman
Sarah K Volkman
DPDaniel Park
Daniel Park
PMPhilip Montgomery
Philip Montgomery
DWDyann F Wirth
Dyann F Wirth
Background: The malaria parasite Plasmodium falciparum exhibits abundant genetic diversity, and this diversity is key to its success as a pathogen. Previous efforts to study genetic diversity in P. falciparum have begun to elucidate the demographic history of the species, as well as patterns of population structure and patterns of linkage disequilibrium within its genome. Such studies will be greatly enhanced by new genomic tools and recent large-scale efforts to map genomic variation. To that end, we have developed a high throughput single nucleotide polymorphism (SNP) genotyping platform for P. falciparum. Results: Using an Affymetrix 3,000 SNP assay array, we found roughly half the assays (1,638) yielded high quality, 100% accurate genotyping calls for both major and minor SNP alleles. Genotype data from 76 global isolates confirm significant genetic differentiation among continental populations and varying levels of SNP diversity and linkage disequilibrium according to geographic location and local epidemiological factors. We further discovered that nonsynonymous and silent (synonymous or noncoding) SNPs differ with respect to within-population diversity, inter-population differentiation, and the degree to which allele frequencies are correlated between populations. Conclusions: The distinct population profile of nonsynonymous variants indicates that natural selection has a significant influence on genomic diversity in P. falciparum, and that many of these changes may reflect functional variants deserving of follow-up study. Our analysis demonstrates the potential for new high-throughput genotyping technologies to enhance studies of population structure, natural selection, and ultimately enable genome-wide association studies in P. falciparum to find genes underlying key phenotypic traits.

24 September 2008 in Malaria Journal
Verified
Journal Article
Open access
PDF file
FLFabiana Ms Leoratti
Fabiana Ms Leoratti
RDRui R Durlacher
Rui R Durlacher
MLMarcus Vg Lacerda
Marcus Vg Lacerda
MAMaria G Alecrim
Maria G Alecrim
AFAntonio W Ferreira
Antonio W Ferreira
SMSandra L Moraes
Sandra L Moraes
Background: The development of protective immunity against malaria is slow and to be maintained, it requires exposure to multiple antigenic variants of malaria parasites and age-associated maturation of the immune system. Evidence that the protective immunity is associated with different classes and subclasses of antibodies reveals the importance of considering the quality of the response. In this study, we have evaluated the humoral immune response againstPlasmodium falciparumblood stages of individuals naturally exposed to malaria who live in endemic areas of Brazil in order to assess the prevalence of different specific isotypes and their association with different malaria clinical expressions.Methods: Different isotypes againstP. falciparumblood stages, IgG, IgG1, IgG2, IgG3, IgG4, IgM, IgE and IgA, were determined by ELISA. The results were based on the analysis of different clinical expressions of malaria (complicated, uncomplicated and asymptomatic) and factors related to prior malaria exposure such as age and the number of previous clinical malaria attacks. The occurrence of the H131 polymorphism of the FcγIIA receptor was also investigated in part of the studied population.Results: The highest levels of IgG, IgG1, IgG2 and IgG3 antibodies were observed in individuals with asymptomatic and uncomplicated malaria, while highest levels of IgG4, IgE and IgM antibodies were predominant among individuals with complicated malaria. Individuals reporting more than five previous clinical malaria attacks presented a predominance of IgG1, IgG2 and IgG3 antibodies, while IgM, IgA and IgE antibodies predominated among individuals reporting five or less previous clinical malaria attacks. Among individuals with uncomplicated and asymptomatic malaria, there was a predominance of high-avidity IgG, IgG1, IgG2 antibodies and low-avidity IgG3 antibodies. The H131 polymorphism was found in 44.4% of the individuals, and the highest IgG2 levels were observed among asymptomatic individuals with this allele, suggesting the protective role of IgG2 in this population.Conclusion: Together, the results suggest a differential regulation in the anti-P. falciparumantibody pattern in different clinical expressions of malaria and showed that even in unstable transmission areas, protective immunity against malaria can be observed, when the appropriated antibodies are produced.

1 June 2007 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
MSMartha Cecilia Suárez-Mutis
Martha Cecilia Suárez-Mutis
PCPatricia Cuervo
Patricia Cuervo
FLFabiana M S Leoratti
Fabiana M S Leoratti
SMSandra L Moraes-Avila
Sandra L Moraes-Avila
AFAntonio Walter Ferreira
Antonio Walter Ferreira
JCJosé Rodrigues Coura
José Rodrigues Coura
A parasitological, clinical, serological and molecular cross-sectional study carried out in a highly endemic malaria area of Rio Negro in the Amazon State, Brazil, revealed a high prevalence of asymptomatic Plasmodium vivax infection. A total of 109 persons from 25 families were studied in five villages. Ninety-nine inhabitants (90.8%) had at least one previous episode of malaria. Serology showed 85.7% and 46.9% of positivity when P. falciparum antigens and P. vivax MSP-1, respectively, were used. Twenty blood samples were PCR positive for P. vivax (20.4%) and no P. falciparum infection was evidenced by this technique. No individual presenting positive PCR reaction had clinical malaria during the survey neither in the six months before nor after, confirming that they were cases of asymptomatic infection. Only one 12 year old girl presented a positive thick blood smear for P. vivax. This is the first description of asymptomatic Plasmodium infection in this area studied.

1 February 2001 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
SASandra L.M. Avila
Sandra L.M. Avila
AGAnna Carla Goldberg
Anna Carla Goldberg
VAViviana G. Arruk
Viviana G. Arruk
MMMaria Lúcia Marin
Maria Lúcia Marin
LGLuiza Guilherme
Luiza Guilherme
AFAntonio Walter Ferreira
Antonio Walter Ferreira

1 September 1998 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
SASandra L.M. Avila
Sandra L.M. Avila
TTTania R. Tozetto-Mendoza
Tania R. Tozetto-Mendoza
VAViviana G. Arruk
Viviana G. Arruk
AFAntonio Walter Ferreira
Antonio Walter Ferreira
The objective of the present study is to standardize the technical variables for preparation and storage of Plasmodium falciparum and of antigen components extracted with the amphoteric detergent Zwittergent. P. falciparum obtained from in vitro culture was stored at different temperatures and for different periods of time. For each variable, antigen components of the parasite were extracted in the presence or absence of protease inhibitors and submitted or not to later dialysis. Products were stored for 15, 30 and 60 days at different temperatures and immunological activity of each extract was determined by SDS-PAGE and ELISA using positive or negative standard sera for the presence of IgG directed to blood stage antigens of P. falciparum. Antigen extracts obtained from parasites stored at -20oC up to 10 days or at -70oC for 2 months presented the best results, showing well-defined bands on SDS-PAGE and Western blots and presenting absorbance values in ELISA that permitted safe differentiation between positive and negative sera.

24 February 2011 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
NMN. G. Muller
N. G. Muller
RAR. Alencar
R. Alencar
LJL. Jamal
L. Jamal
JHJ. Hammer
J. Hammer
JSJ. Sidney
J. Sidney
SMS. L. Moraes
S. L. Moraes
Human immunodeficiency virus (HIV)-1 protease is a known target of CD8+ T cell responses, but it is the only HIV-1 protein in which no fully characterized HIV-1 protease CD4 epitopes have been identified to date. We investigated the recognition of HIV-1 protease by CD4+ T cells from 75 HIV-1-infected, protease inhibitor (PI)-treated patients, using the 5,6-carboxyfluorescein diacetate succinimidyl ester-based proliferation assay. In order to identify putative promiscuous CD4+ T cell epitopes, we used the TEPITOPE algorithm to scan the sequence of the HXB2 HIV-1 protease. Protease regions 4–23, 45–64 and 73–95 were identified; 32 sequence variants of the mentioned regions, encoding frequent PI-induced mutations and polymorphisms, were also tested. On average, each peptide bound to five of 15 tested common human leucocyte antigen D-related (HLA-DR) molecules. More than 80% of the patients displayed CD4+ as well as CD8+ T cell recognition of at least one of the protease peptides. All 35 peptides were recognized. The response was not associated with particular HLA-DR or -DQ alleles. Our results thus indicate that protease is a frequent target of CD4+ along with CD8+ proliferative T cell responses by the majority of HIV-1-infected patients under PI therapy. The frequent finding of matching CD4+ and CD8+ T cell responses to the same peptides may indicate that CD4+ T cells provide cognate T cell help for the maintenance of long-living protease-specific functional CD8+ T cells.